Alchemist has informed that pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015 as amended, read with NSE Circular No: NSE/CML/2019/11 and BSE Circular No: LIST/COMP/01/2019-20 dated 2nd April, 2019; the Trading Window for dealing in the securities of the Company shall remain closed for all Designated/ Connected Persons with effect from Friday, January 01, 2021 till the end of 48 hours after declaration of Unaudited Financial Results for the Quarter ended on December 31, 2020. All the Directors, KMPs, Designated Employees, connected persons and their immediate relatives are advised not to deal in the shares of the Company either directly or indirectly during the aforesaid period. The date of Board Meeting for consideration and declaration of the Unaudited Financial Results for the Quarter ended on December 31, 2020 shall be intimated separately.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: